col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


19 Results       Page 1

 [1] 
Nepal Journals Online: Journal of Biomedical Sciences
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2023―Feb―06 D-Dimer as a biomarker for COVID-19 patients' illness severity and mortality: A hospital-based study from eastern Nepal Ankush Mittal, Mohammad Shamim Farooqui
2 [GO] 2021―Dec―31 Study of dynamic changes in the parameters of liver function tests in COVID-19 patients: A hospital-based study in Eastern Nepal Ankush Mittal, Mohammad Shamim Farooqui
3 [GO] 2021―Dec―31 Patient with false negative RT-PCR for COVID-19 referred to cancer hospital for lung cancer screening: A case report Ajay Kumar Yadav, Suman Gnawali, Sandip Mandal, Gyan Bahadur Shrestha, Gangbiao Yuan
4 [GO] 2021―Dec―31 mRNA COVID-19 vaccine: A future hope for cancer treatment Ajay Kumar Yadav, Suman Gnawali, Sandip Mandal, Gyan Bahadur Shrestha, Gangbiao Yuan
5 [GO] 2021―Dec―31 The Omicron variant of COVID-19: Is it the final nail in the coffin of the SARS-CoV-2 pandemic? Bedanta Roy, Harekrishna Roy
6 [GO] 2021―Jul―18 Knowledge, attitude, and practice on COVID-19 among undergraduate students of B. P. Koirala Institute of Health Sciences, Dharan, Nepal: An online cross-sectional survey KR Pandey, DR Panday, P Pyakurel, S Marahatta, SP Rimal, M Dali, R Gyawali, Rambha Sigdel, N Bhattarai, N Limbu, GP Rauniar
7 [GO] 2021―Jul―18 Gastrointestinal manifestations as early symptoms to diagnose COVID-19 paediatric cases J Robinson, I Banerjee, A Leclézio
8 [GO] 2021―Jul―18 Epileptic seizures in patients with COVID-19: A systematic review of early evidences B Roy, I Banerjee
9 [GO] 2021―Jul―18 Global variants of COVID-19: Current understanding B Roy, JK Dhillon, N Habib, B Pugazhandhi
10 [GO] 2021―Jul―18 Novel drug for COVID-19: Virafin a therapeutic breakthrough J Robinson, I Banerjee, B Roy, A Leclézio
11 [GO] 2021―Jul―18 The Delta Plus variant of COVID-19: Will it be the worst nightmare in the SARS-CoV-2 pandemic? Bedanta Roy, Harekrishna Roy
12 [GO] 2021―Jan―02 Azithromycin and Hydroxychloroquine combination: The future pharmacotherapy of COVID-19 Ananya Shukla, Pornasha Mohabeer, Abhishek Kashyap, Jared Robinson, Indrajit Banerjee
13 [GO] 2021―Jan―02 COVID-19 and neurological complications: Is it alarming? Bedanta Roy
14 [GO] 2021―Jan―02 SARS-CoV-2 - an update in virology: A Narrative Review Poornasha Mohabeer, Indrajit Banerjee, Abishek Kashyap, Ananya Shukla, Jared Robinson, Nikhil D. Ramdhan
15 [GO] 2020―Jul―03 COVID-19 pandemic: How close are we for an effective therapy? Bedanta Roy
16 [GO] 2020―Jul―03 COVID-19: Recent advances in epidemiology, virology, etiopathogenesis, clinical trials and vaccine development Indrajit Banerjee, Poormasha Mohabeer, Ananya Shukla, Abhishek Kashyap, Jared Robinson
17 [GO] 2020―Jul―03 ABO blood groups as determinants to patient outcomes in SARS-CoV-2 Jared Robinson, Indrajit Banerjee, Brijesh Sathian, Alexandra Leclézio, Bedanta Roy
18 [GO] 2020―Jul―03 SARS-CoV-2: ACE inhibitors, disastrous or desirable? Alexandra Leclézio, Jared Robinson, Indrajit Banerjee
19 [GO] 2020―Jul―01 Pediatric COVID-19 Patients in Jeddah, Saudi Arabia: Clinical, Laboratory and Radiological Aspects Sumayyah Ahmed Nezar Kobeisy, Saleh Al Harbi, Raja Saleh Mehdawi, Dina Salem Bashammakh
 [1] 

19 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec